TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Leo Pharma AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
3,960
|
4,655
|
5,421 |
Financial expenses |
4
|
12
|
8 |
Earnings before taxes |
214
|
191
|
69 |
Total assets |
3,515
|
3,139
|
2,955 |
Current assets |
3,514
|
3,139
|
2,955 |
Current liabilities |
1,932
|
1,627
|
1,517 |
Equity capital |
1,583
|
1,512
|
1,439 |
- share capital |
267
|
285
|
301 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
45.0%
|
48.2%
|
48.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
5.4%
|
4.1%
|
1.3% |
Return on assets (ROA) |
6.2%
|
6.5%
|
2.6% |
Current ratio |
181.9%
|
192.9%
|
194.8% |
Return on equity (ROE) |
13.5%
|
12.6%
|
4.8% |
Change turnover |
-398
|
-482
|
-2,033 |
Change turnover % |
-9%
![]() |
-9%
|
-27% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.